Interactions between exogenous Insulin Aspart, endogenous insulin and plasma glucose in type 2 diabetes mellitus patients [Interaktioner mellem eksogent Insulin Aspart, endogent insulin og plasma glukose ved type 2 diabetes mellitus]

Trial Profile

Interactions between exogenous Insulin Aspart, endogenous insulin and plasma glucose in type 2 diabetes mellitus patients [Interaktioner mellem eksogent Insulin Aspart, endogent insulin og plasma glukose ved type 2 diabetes mellitus]

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Jan 2013

At a glance

  • Drugs Insulin aspart (Primary) ; Glucose
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacokinetics
  • Most Recent Events

    • 01 Jan 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 07 Apr 2012 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database record.
    • 07 Apr 2012 Actual initiation date (22 Dec 2011) added as reported by European Clinical Trials Database record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top